Involvement of the renin-angiotensin system in the development of left ventricular hypertrophy and dysfunction
- PMID: 7884580
Involvement of the renin-angiotensin system in the development of left ventricular hypertrophy and dysfunction
Abstract
Objectives: To elucidate the regulation of cardiac gene expression by mechanical stress and to analyse molecular mechanisms associated with the involvement of angiotensin II (Ang II) in the development of cardiac hypertrophy and dysfunction.
Methods: Neonatal rat cardiocytes were cultured in deformable silicone dishes, and mechanical stress was imposed on the cardiocytes by stretching them. In in vivo studies, spontaneously hypertensive rats (SHR) were treated with a non-peptide, specific Ang II type 1 receptor antagonist, TCV 116.
Results: Expression of the c-fos gene was rapidly induced, and fetal type genes such as skeletal alpha actin and beta myosin heavy chain genes were re-expressed by stretching. The mechanical stress decreased the expression of Ca(2+)-ATPase in the sarcoplasmic reticulum. With regard to signals for the development of cardiac hypertrophy, mechanical stress evoked c-fos expression via the activation of protein kinase C. The phosphorylation cascade (sequential activation of protein kinase C, Raf-1 kinase, mitogen-activated protein kinase kinase, mitogen-activated protein kinase and S6 kinase), which may be involved in protein synthesis and gene expression, was activated by mechanical stress in cardiocytes. Stretch-induced cardiac cellular hypertrophy was partially inhibited by TCV 116. TCV 116 treatment of SHR reduced left ventricular weight, left ventricular wall thickness, myocyte transverse diameter, V3 myosin heavy chain levels and the interstitial collagen volume fraction.
Conclusions: These results indicate that AngII may, in part, mediate the stretch-induced hypertrophic growth of cardiomyocytes via the type 1 Ang II receptor.
Similar articles
-
Involvement of the renin-angiotensin system in the development of left ventricular hypertrophy and dysfunction.J Hypertens Suppl. 1994 Dec;12(10):S153-7. J Hypertens Suppl. 1994. PMID: 7769485 Review.
-
Angiotensin II receptor antagonist TCV-116 induces regression of hypertensive left ventricular hypertrophy in vivo and inhibits the intracellular signaling pathway of stretch-mediated cardiomyocyte hypertrophy in vitro.Circulation. 1994 May;89(5):2204-11. doi: 10.1161/01.cir.89.5.2204. Circulation. 1994. PMID: 8181146
-
Renin-angiotensin system and myocardial collagen matrix: modulation of cardiac fibroblast function by angiotensin II type 1 receptor antagonism.J Hypertens Suppl. 1997 Dec;15(6):S13-9. J Hypertens Suppl. 1997. PMID: 9493122
-
Role of the renin-angiotensin system in cardiac hypertrophy.Am J Cardiol. 1999 Jun 17;83(12A):53H-57H. doi: 10.1016/s0002-9149(99)00259-3. Am J Cardiol. 1999. PMID: 10750588 Review.
-
Serial changes in sarcoplasmic reticulum gene expression in volume-overloaded cardiac hypertrophy in the rat: effect of an angiotensin II receptor antagonist.Clin Sci (Lond). 1999 Apr;96(4):387-95. Clin Sci (Lond). 1999. PMID: 10087246
Cited by
-
Impact of AT2 receptor deficiency on postnatal cardiovascular development.PLoS One. 2012;7(10):e47916. doi: 10.1371/journal.pone.0047916. Epub 2012 Oct 29. PLoS One. 2012. PMID: 23144713 Free PMC article.
-
Renin angiotensin system and cardiac hypertrophy after sinoaortic denervation in rats.Clinics (Sao Paulo). 2010;65(12):1345-50. doi: 10.1590/s1807-59322010001200019. Clinics (Sao Paulo). 2010. PMID: 21340225 Free PMC article.
-
Heart failure in blacks: etiologic and epidemiologic differences.Curr Cardiol Rep. 2001 May;3(3):191-7. doi: 10.1007/s11886-001-0022-0. Curr Cardiol Rep. 2001. PMID: 11305972 Review.
-
Control of cardiomyocyte gene expression as drug target.Mol Cell Biochem. 2000 Sep;212(1-2):135-42. Mol Cell Biochem. 2000. PMID: 11108145 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Research Materials
Miscellaneous